7
Participants
Start Date
November 7, 2023
Primary Completion Date
May 31, 2025
Study Completion Date
May 31, 2025
CRD-4730
Oral CRD-4730 in capsule form
Placebo
Placebo to match CRD-4730 in capsule form
IRCCS Pavia Istituti Clinici Scientifici Maugeri Spa Società Benefit, Pavia
Cleveland Clinic Children's Hospital, Cleveland
Hôptal Nord Laennec, Nantes
Cincinnati Children's Hospital Medical Center, Cincinnati
Hôpital Louis Pradel, Bron
Groupe Hospitalier Bichat Claude Bernard, Paris
Baylor College of Medicine, Houston
Stollery Children's Hospital University of Alberta, Edmonton
University of British Columbia (UBC) Hospital, Vancouver
British Columbia Children's Hospital, Vancouver
University of Western Ontario, London
Lead Sponsor
Cardurion Pharmaceuticals, Inc.
INDUSTRY